Clinical trials show promise in treating central n

Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lym

Related Keywords

Chicago ,Illinois ,United States ,Boston ,Massachusetts ,Dana Farber Cancer Institute ,American ,Patrick Wen ,Janetl Abrahm ,Gilbert Youssef ,Lakshmi Nayak ,Sara Tolaney ,Caron Jacobson ,Narjust Florez ,Walther Cancer Foundation Supportive Oncology Award ,Dana Farber Brigham Cancer Center ,Blood Disorders Center ,American Society Of Clinical Oncology ,American Society ,Clinical Oncology ,Dana Farber Oral Presentations ,Dana Farber Poster Discussions ,Abstract Number ,Oral Abstract Session ,Nervous Tumors ,Lead Author ,Cancer Metastatic ,Ana Garrido Castro ,Rapid Oral Abstract Session ,Nervous System Tumors ,Shail Maingi ,Victoria Warren ,Dana Farber News ,Farber Cancer Institute ,Boston Children ,Blood Disorders ,World Report Best Cancer Hospital ,